Waverley Pharma Inc (WAVE) — Financial Flexibility Index
Waverley Pharma Inc (WAVE) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of CA$-138.86K (operating CF CA$-138.86K minus capex CA$0.00) represents 0% of total liabilities (CA$3.64 Million). Also explore WAVE shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Waverley Pharma Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Waverley Pharma Inc across 10 annual periods. See WAVE equity to assets ratio to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Waverley Pharma Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Waverley Pharma Inc. For the full company profile including market capitalisation, see WAVE company net worth.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.10x | CA$-410.19K | CA$-410.19K | CA$4.08 Million | ▲ +79.4% |
| 2023 | -0.49x | CA$-1.02 Million | CA$-1.02 Million | CA$2.09 Million | ▼ -229.1% |
| 2022 | -0.15x | CA$-237.06K | CA$-237.06K | CA$1.60 Million | ▲ +64.8% |
| 2021 | -0.42x | CA$-798.78K | CA$-798.78K | CA$1.89 Million | ▼ -68.9% |
| 2020 | -0.25x | CA$-361.70K | CA$-361.70K | CA$1.45 Million | ▲ +72.6% |
| 2019 | -0.91x | CA$-1.41 Million | CA$-1.41 Million | CA$1.55 Million | ▲ +20.6% |
| 2018 | -1.15x | CA$-1.45 Million | CA$-1.45 Million | CA$1.26 Million | ▼ -1592.1% |
| 2017 | -0.07x | CA$-108.69K | CA$-108.69K | CA$1.60 Million | ▲ +99.3% |
| 2016 | -9.27x | CA$-108.69K | CA$-108.69K | CA$11.72K | ▲ +9.2% |
| 2015 | -10.21x | CA$-108.69K | CA$-108.69K | CA$10.65K | — |